BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fell S, Wang Z, Blanchard A, Nanthakumar C, Griffin M. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors. Amino Acids 2021;53:205-17. [PMID: 33474654 DOI: 10.1007/s00726-020-02938-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kolligundla LP, Gupta S, Lata S, Mulukala SKN, Killaka P, Akif M, Pasupulati AK. Identification of Novel GTP Analogs as Potent and Specific Reversible Inhibitors for Transglutaminase 2. Molecular Simulation. [DOI: 10.1080/08927022.2022.2123917] [Reference Citation Analysis]
2 Hauser S, Sommerfeld P, Wodtke J, Hauser C, Schlitterlau P, Pietzsch J, Löser R, Pietsch M, Wodtke R. Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates. Int J Mol Sci 2022;23:4475. [PMID: 35562866 DOI: 10.3390/ijms23094475] [Reference Citation Analysis]
3 Keillor JW, Johnson GVW. Transglutaminase 2 as a therapeutic target for neurological conditions. Expert Opin Ther Targets 2021;25:721-31. [PMID: 34607527 DOI: 10.1080/14728222.2021.1989410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tatsukawa H, Hitomi K. Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis. Cells 2021;10:1842. [PMID: 34360011 DOI: 10.3390/cells10071842] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Noskovicova N, Hinz B, Pakshir P. Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction. Cells 2021;10:1794. [PMID: 34359963 DOI: 10.3390/cells10071794] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
6 Tempest R, Guarnerio S, Maani R, Cooper J, Peake N. The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment. Cancers (Basel) 2021;13:2788. [PMID: 34205140 DOI: 10.3390/cancers13112788] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]